Navigation Links
Will new methods that increase blood flow to bone implants improve viability of engineered bone tissue?
Date:10/25/2012

New Rochelle, NY, October 22, 2012New, advanced techniques are needed that can mimic the normal blood supply that feeds natural bone to improve the viability and success of restorative procedures to replace damaged or diseased bone tissue using engineered constructs. A comprehensive review article describing the most promising strategies for vascularization of bone tissue substitutes is published in Tissue Engineering, Part B: Reviews, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free online on the Tissue Engineering website.

The lack of an adequate blood supply to engineered bone implants has been a major limiting factor in the ability of these large tissue engineered implants to survive and integrate in the body. Many new strategies for stimulating the growth of new blood vessels and the formation of a vascular network to carry nutrients and oxygen and aid in healing are in development, as presented by Lonnissa H. Nguyen, PhD, and coauthors from Massachusetts Institute of Technology (Cambridge); Brigham and Women's Hospital, Harvard University, and Harvard Medical School (MA); Ecole Polytechnique (Palaiseau, France); Chonnam National University (Gwangju, South Korea); Stanford University (CA); Tohoku University (Sendai, Japan). They describe the different methods and their limitations in the article "Vascularized Bone Tissue Engineering: Approaches for Potential Improvement."

"There is a critical need to develop innovative techniques for tissue vascularization, and the work by Nguyen et al. demonstrates both past successes in the field and future avenues for investigation," says Reviews Co-Editor-in-Chief John P. Fisher, PhD, Professor and Associate Chair, Fischell Department of Bioengineering, University of Maryland, College Park, MD.


'/>"/>

Contact: Cathia Falvey
cfalvey@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology technology :

1. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
2. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
3. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
4. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
5. NIH media availability: Protein linked to increased risk of heart failure and death in older adults
6. Increased productivity, not less energy use, results from more efficient lighting
7. Increase in Genomic Replikin Counts Predicted Recent Avian Flu (H5N1) Outbreak in Cambodia
8. iDiverse Discovers Yeast Gene that Increases Fuel Ethanol Production Yield
9. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
10. Trade Show Display Company GLM Displays Increase Sales with New E-commerce Website
11. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... , ... Global Stem Cells Group CEO Benito Novas announced that ... GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in ... hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM Professor ...
(Date:4/26/2016)... , ... April 26, 2016 , ... ... announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, ... bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of ...
(Date:4/26/2016)... ... April 26, 2016 , ... BioFactura, Inc ., ... A round of financing. Healthy investor interest drove significant oversubscription of the original ... biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer and ...
(Date:4/26/2016)... 26, 2016 genae, a Contract ... industries, announced today the appointment of Prof. Dr. Jörn ... Balzer,s responsibilities will include all clinical, safety and risk ... feel privileged and honored with the acceptance of Prof. ... , CEO at genae. "Prof. Balzer,s impressive and extensive ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):